- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01480882
Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory Passage (LEGA)
"A Prospective, Cross-over Randomized Trial to Assess the Efficacy and Safety of Mechanical Percussor "LEGA" Compared With Conventional Chest Physiotherapy in Adults With Chronic Bronchiectasis or Chronic Obstructive Pulmonary Disease (COPD
A Malaysian company by name Formedic Technologies SDN BHD has devised a hand held machine which is supposed to mimic the chest percussion performed by professional physiotherapist to mobilize sputum through the respiratory passage.
The aim of this study is to compare the effectiveness and safety of this mechanical percussion device in the treatment of airway clearance with conventional chest physiotherapy carried out by qualified physiotherapists in patients suffering from bronchiectasis or Chronic obstructive Pulmonary disease (COPD).
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Penang
-
George Town, Penang, Malaysia, 10990
- Penang Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients > 18 years of age
- Chronic sputum expectoration-(producing >30ml/day of sputum at baseline)
- Clinical diagnosis of bronchiectasis or COPD
- Not carrying out regular chest physiotherapy (for the purposes of this study this will be defined as less than two occasions per week)
- Clinically stable disease (defined as no requirement for antibiotics in the 4 weeks preceding study entry).
- FEV1 of > 35% of the predicted value in COPD patients
Exclusion Criteria:
- Primary diagnosis of asthma;
- Active sarcoidosis
- Active Pulmonary tuberculosis.
- History of brittle bones,
- History of broken ribs in the past one year.
- History of severe osteoporosis
- Bleeding from the lungs or haemoptysis
- Experiencing intense pain in the thoracic region
- Clinical suspicion of increased intracranial pressure.
- Have head or neck injuries
- Have collapsed lungs or a damaged chest wall;
- Recent myocardial infarction, unstable angina and stroke (Within 6 months prior to enrollment)
- Have a pulmonary embolism or lung abscess;
- Have an active hemorrhage
- Have injuries to the spine
- Have open wounds or burns in the thoracic region
- Have had recent surgery (Within six months prior to enrollment.)
- Any systemic steroids within 4/52 prior to enrollment
- Any antibiotics within 4/52 prior to enrollment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Conventional Chest PhysioTherapy
Conventional Chest Physiotherapy (CCPT) is delivered by professional physiotherapist for 15 minutes.
|
Conventional chest percussion will be applied for a duration of 15 minutes.
Other Names:
|
|
Experimental: Mechanical percussion
Mechanical percussion will be delivered by a device called "LEGA" for 15 minutes
|
Mechanical chest percussion will be delivered by a device for 15 minutes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparing the 'wet weight' and 'dry weight' of the sputum expectorated during 20 minutes of the two procedures.
Time Frame: 6 days
|
The patients will be instructed to cough out the sputum into a preweighed container during the 15 minutes of the procedure(Manual or mechanical percussion)and 5 minutes after the procedure.Container will be weighed to get the wet weight of the sputum then will be dried in a laboratory oven at 60degree c for 48 hours and weighed again to get the dry weight of the sputum
|
6 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in FEV1 and FVC before and after the two methods of therapy
Time Frame: 15 minutes after completion of the procedure compared to baseline
|
Any changes in the lung function will be measured as - FEV1 (%predicted) and FVC (%predicted)
|
15 minutes after completion of the procedure compared to baseline
|
|
Changes in pulse, blood pressure and respiratory rate
Time Frame: 15 minutes after completion of treatment compared to baseline
|
Monitoring of Pulse, blood pressure, respiratory rate, skin colour and patients reaction to treatment.
|
15 minutes after completion of treatment compared to baseline
|
|
Patient preference
Time Frame: After completing 6 days of participation in the study
|
Patients will be participating in the study for 6 days.
On the 6th day after completion of treatment they will be required to answer a simple questionnaire to find out if they prefer one procedure over the other and why.
|
After completing 6 days of participation in the study
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ong L Meng, MBBS, FRCP, Penang Hospital, Malaysia
- Principal Investigator: Mohd I Izmi, MBBS, MD, Penang Hospital, Malaysia
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CT-11-HPP-001
- NMRR-11-661-10072 (Registry Identifier: National Medical Reseach Register (NMRR))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Morair Medtech, LLCRecruitingEmphysema | COPD | Emphysema or COPD | COPD (Chronic Obstructive Pulmonary Disease) | Emphysema, PulmonaryAustria, Germany, Netherlands
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Barron Associates, Inc.National Heart, Lung, and Blood Institute (NHLBI); University of VirginiaNot yet recruitingCOPD | COPD - Chronic Obstructive Pulmonary DiseaseUnited States
-
Elpen Pharmaceutical Co. Inc.Completed
Clinical Trials on Conventional Chest Physiotherapy (CCPT)
-
Bezmialem Vakif UniversityCompleted
-
Hospital Sirio-LibanesCompletedViral BronchiolitisBrazil
-
Beni-Suef UniversityNot yet recruitingOsteopathic Manipulative TreatmentEgypt
-
Riphah International UniversityNot yet recruitingPneumonia | Bronchiectasis | Asthma | Pulmonary Fibrosis | TuberculosisPakistan
-
Bezmialem Vakif UniversityCompleted
-
Bezmialem Vakif UniversityActive, not recruitingInterstitial Lung DiseaseTurkey
-
Universidade Cidade de Sao PauloConselho Nacional de Desenvolvimento Científico e TecnológicoCompleted
-
Universidade Federal de Sao CarlosCompletedLung Disease | Obesity, AbdominalBrazil
-
Capital Medical UniversityNot yet recruiting